Breakout Session I
Aligned Feasibility: Showcasing Site Reach & Access
How can sites showcase their patient reach capabilities during the feasibility process to align with sponsor expectations? Join us to explore best practices and strategies for highlighting site strengths and factors that contribute to successful site partnerships. Hear from sponsors and CROs on how they assess feasibility with a focus on participant accessibility and representation to ensure trials are more reflective of the communities they serve
Building Trust & Engagement For Inclusive Research
Explore strategies for fostering trust and engagement with underrepresented communities in clinical research. This forum highlights the essential role of community leaders in encouraging clinical trial participation, showcasing case studies that utilize digital platforms and social media as powerful outreach tools. Discuss proven strategies to build sustainable partnerships, leverage technology, and advance inclusivity in research.
Inclusivity Forum: Indigenous Peoples
This forum offers a collaborative space to explore solutions, best practices, and challenges in fostering a more inclusive clinical research environment for Indigenous populations. Share insights, exchange knowledge, and work together toward building more representative and equitable clinical research experiences and outcomes.
Inclusivity Forum: Sexual & Gender Minorities
This session is dedicated to addressing the unique challenges and best practices for including sexual and gender minorities (SGM) in clinical research. This open discussion will focus on enhancing diversity and equity in trials for SGM populations, providing a platform to develop collaborative strategies and plans for a more inclusive research environment.
Understanding Site Needs Through The DSAT
The SCRS Diversity Site Assessment Tool (DSAT) is a crucial resource for evaluating site capabilities in patient recruitment and trial management, providing valuable industry data on site needs. Hear from the IncluDE DSAT Working Group members about how the updated tool is used and its impact on enhancing representation and access in clinical trials